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Abstract Virus recognition and induction of interferon
(IFN) are critical components of the innate immune system.
The Toll-like receptor (TLR) and RIG-I-like receptor
families have been characterized as key players in RNA
virus detection. Signaling cascades initiated by these
receptors are crucial for establishment of an IFN signaling
mediated antiviral state in infected and neighboring cells
and containment of virus replication as well as initiation of
the adaptive immune response. In this review, we focus on
the diverse and overlapping functions of these receptors,
their physiological importance, and respective viral
inducers. We highlight the roles of TRL3, TLR7/8, retinoic
acid inducible gene I, melanoma differentiation-associated
gene 5, and the RNA molecules responsible for activating
these viral sensors.
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Interferon
The phenomenon of host directed viral interference has
been observed for many years, with some descriptions
dating back to observations made by Jenner in 1804
in reference to herpes virus infections interfering with
vaccinia virus lesion developments. Supporting these initial
reports, more controlled studies with numerous bacteria,
plant, and animal viruses followed in the 1930s and 1940s
and further conﬁrmed the viral interference phenomena. A
thorough and detailed review by Henle describes many
pioneering studies and provides numerous examples of
initial reports of viral interference (Henle 1950). These
early studies varied widely in their approach with some
using live or inactivated virus as an interfering agent and
challenging with either the same or different species
of virus. Through hindsight, it becomes clear that many of
these initial experiments were not relevant to the action of
interferon but could be attributed to other phenomena
where the end result was inhibition of viral infection.
Nevertheless, numerous important and relevant observa-
tions were made in those early years of research and
placing these initial ﬁndings in the context of current
molecular biology knowledge provides a deeper under-
standing of the ﬁeld and also highlights areas in need of
elucidation.
Experiments done with inactivated inﬂuenza virus in
embryonated chicken eggs have provided some of the
clearest early data relating to the interference phenomenon.
From results generated by multiple groups, it became clear
that interference can be caused by either inactivated virus
particles or live virus grown under speciﬁc conditions,
such as repeated passage with large inocula or repeated
freeze-thawing. It also became apparent that the method
of inactivation was highly important for the degree of
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heat or formalin treatment. The length of UV treatment
corresponded to an increase in interfering ability until a
peak was reached and decreased with further exposure
(Ziegler et al. 1944). Furthermore, the replication ability of
a virus was much more sensitive to UV treatment than the
interfering ability. Based on these early observations, many
proposals as to the mechanism of interference were made,
including the conclusion that this phenomenon was caused
by a cellular product resulting from primary viral infection
(Henle 1950). Further support for this hypothesis came
from the now famous work of Isaacs and Lindenmann who
coined the term ‘interferon’ and described it as a ‘non-
hemagglutinating macromolecular particle which has many
different properties from those of heated inﬂuenza virus’
(Isaacs and Lindenmann 1957). Over the next 30 years,
type I interferon (IFN) was characterized in detail and
identiﬁed as a family of cytokines encoded by the IFN-b
gene and multiple IFN-a genes. After an arduous struggle,
human IFN was puriﬁed to homogeneity and characterized
for its biochemical properties by three individual groups,
which identiﬁed its acid-stability and amino acid compo-
sition (Rubinstein et al. 1978, 1979; Tan et al. 1979; Zoon
et al. 1979). Consequently, the availability of puriﬁed IFN
and subsequent cloning and expression of the IFN-b gene
product from E. coli allowed much more detailed analysis
of its antiviral action (Nagata et al. 1980). Today, IFN is
known as a key component of the innate immune system
responsible not only for broad cellular antimicrobial
activity in response to primary infection, but also for its
role in linking innate and adaptive immune responses
(Biron 2001).
Viral inducers
Shortly following the discovery of IFN, viral RNA was
proposed to be the inducer of this antiviral response (Isaacs
et al. 1963). Many early studies focused on possible nucleic
acid inducers and numerous synthetic and biological RNAs
were tested for their ability to induce interferon. Common
to most of these studies, dsRNA was found to be a potent
trigger of the interferon response unlike ssRNA, DNA or
RNA:DNA hybrids (Colby and Morgan 1971). Speciﬁ-
cally, dsRNA from bacteria, reovirus, vaccinia virus and
synthetic polyinosinic:polycytidylic acid poly(I:C) were
shown to be potent activators of the antiviral response
(Colby and Duesberg 1969; Field et al. 1967, 1968;
Lampson et al. 1967; Tytell et al. 1967). Since then many
groups have conﬁrmed the strong IFN inducing ability of
poly(I:C). The biochemical basis for its high level of
activation remains unclear to this day, as it does not appear
that stability of the RNA complex directly correlates with
its IFN inducing capacity (Colby and Morgan 1971). Based
on dsRNA’s induction capacity, the concept of dsRNA as a
physiological viral trigger for IFN induction quickly
became accepted in the ﬁeld despite prevailing evidence
that the majority of RNA viruses employ mechanisms that
protect their RNA from exposure. This conundrum was
largely dismissed with the simple explanation that viruses
are bound to make mistakes during replication and are
therefore likely to expose at least some dsRNA molecules
to the cell. However, studies employing dsRNA-speciﬁc
antibodies have shown that negative-strand RNA viruses
do not appear to produce detectible amounts of dsRNA
(Weber et al. 2006). Although, it is possible that the
threshold amount of dsRNA required to trigger an IFN
response is below the antibody detection limit or that the
length of dsRNA molecules is not sufﬁcient for antibody
recognition. But it is equally plausible that a different
molecule serves as the primary recognition motif for RNA
viruses.
An important addition to the ﬁeld was the discovery that
a5 0 triphosphate (50ppp) group on an RNA molecule also
served as a potent activator of the interferon response and
could provide an alternative/additional trigger to dsRNA
(Hornung et al. 2006; Pichlmair et al. 2006). RNA syn-
thesis by RNA polymerases initiates with a triphosphate
containing nucleotide and therefore all RNA molecules
initially contain a triphosphate moiety on their 50 end.
However, since cells generally process the synthesized
RNA by either capping mRNA, removing 50ppp during
RNA processing, folding RNA into complex secondary
structures, or packaging it into RNP complexes; exposed
50ppp are likely uncommon in the cytoplasm and therefore
provide an appealing viral recognition motif. The genomes
of RNA viruses are known to contain uncapped, 50ppp-
containing RNA, although the question of whether this
RNA is ever exposed to the cell during the viral lifecycle
remains to be answered. Additionally, it makes sense that if
viruses have evolved multiple mechanisms to hide their
dsRNA, they are equally likely to protect their 50ppp from
antiviral sensors.
Because early interference experiments relied on inac-
tivated virus as the inducer of interferon response, attempts
were made to connect the induction by isolated RNA to
that of inactivated virus. An initial report showed that RNA
is produced from UV treated Newcastle Disease Virus
(NDV) virions even though there is a complete loss of
infectivity as measured by plaque assay (Huppert et al.
1969). Thus, it appeared that UV treated virions attempt to
replicate and produce at least partially synthesized RNA
even in the absence of producing functional viral progeny.
This incomplete newly synthesized RNA is thought to
base pair with the template resulting in the formation of a
dsRNA molecule.
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by numerous studies, even though it does appear that under
certain conditions completely inactive virus is capable of
inducing IFN (Hidmark et al. 2005). It remains to be
determined whether this induction by inactivated virus is
due to incomplete inactivation, exposure of viral RNA
resulting from physical damage to the virions, or if other
viral components are capable of being recognized by the
cell. In addition to viral RNA, viral proteins and ribonu-
cleoprotein (RNP) complexes have been implicated in IFN
induction. When introduced into cells, puriﬁed RNP com-
plexes do induce an IFN response (tenOever et al. 2002,
2004). However, since it is extremely difﬁcult to demon-
strate that intact RNPs are introduced into cells, differen-
tiation between RNP recognition and naked RNA
recognition remains elusive. A few examples of viral
protein recognition do exist. Hepatitis C Virus (HCV)
NS5A protein has been shown to activate nuclear factor-jB
(NF-jB) when expressed in cells (Waris et al. 2002). In
addition, the F protein of respiratory syncytial virus (RSV)
is well characterized to be capable of inducing proinﬂam-
matory cytokines through TLR4 (Kurt-Jones et al. 2000).
However, it is unlikely that viral proteins alone are sufﬁ-
cient for induction of an antiviral response based on their
wide diversity and biochemical similarity to cellular pro-
teins. A more plausible scenario is that during a viral
infection, multiple signals are recognized by different
sensors, which in synergy, alert the cell to the presence of a
viral pathogen.
Cellular receptors
To date, two distinct systems for RNA virus detection and
interferon induction have been characterized. One is com-
posed of toll-like receptors (TLRs) and the other is the RIG-
I like receptor (RLR) family. Of the 13 mammalian TLR
members identiﬁed to date, endosomally located TLR3,
TLR7 and TLR8 have been characterized as principal
sensors of RNA viruses, while other TLRs are responsible
for detecting bacteria, fungi, and DNA viruses (Alexopoulou
et al. 2001; Diebold et al. 2004). Extracellularly located
TLR4 has also been implicated in RNA virus detection
through recognition of the F protein of respiratory syncytial
virus (Kurt-Jones et al. 2000). RIG-I and MDA5, of the
RLR family, are cytoplasmic sensors expressed in majority
of cell types and detect intracellular RNA viruses. Viral
RNA is thought to function as the pathogen-associated
molecular pattern (PAMP) for all intracellular RNA virus
pattern-recognition receptors (PRRs), although the exact
biochemical nature of inducing molecules remains unclear.
Current understanding indicates that TLR3 recognizes any
dsRNA in endocytic compartments while MDA5 recog-
nizes long dsRNA in the cytoplasm, TLR7 and 8 are acti-
vated by ssRNA rich in G/U residues in endosomes of
dendritic cells and RIG-I senses phosphate containing
dsRNA in the cytoplasm of majority of cells (Table 1).
Upon detection of their corresponding PAMPs, both TLRs
and RLRs initiate signaling cascades which converge on
activation, and subsequent nuclear localization of three
families of transcription factors: NF-jB, interferon regula-
tory factors (IRFs), and ATF-2/cJun. As can be seen in
Fig. 1, the signaling pathways for TLR3 and RLRs utilize
adaptors TRIF and MAVS, respectively, and then converge
with activation of the canonical (IKKa, b, and c) and non-
canonical (TBK1, IKKe) IKK kinases. Activation of TBK1/
IKKe leads to phosphorylation and nuclear translocation of
IRF3. Whereas IKKa, b, and c activate and allow nuclear
translocation of NF-jB. TLR7 and 8 in dendritic cells uti-
lize a common TLR adaptor MyD88 to activate a complex
of IRAK4/IRAK1/TRAF6, which in turn lead to phos-
phorylation and nuclear translocation of IRF7. These
Table 1 Recognition of RNA substrates and viruses by RNA speciﬁc PRRs
Receptor Localization Substrates Viruses
TLR3 Endosomes of multiple cells
Cell surface of ﬁbroblasts
dsRNA Inﬂuenza A, MCMV, Reovirus,
WNV
TLR7/8 Endosomes of dendritic cells ssRNA rich in G and U residues
Cellular mRNA
Inﬂuenza A, SeV, VSV, HIV
RIG-I Cytoplasm of most cells Partially dsRNA with 5’ppp
U-rich 5’ppp containing RNA
Inﬂuenza A, SeV, VSV, WNV,
NDV, HCV,JEV, rubella,
measles, rabies, reovirus, EBV,
HSV1, adenovirus, dengue
MDA5 Cytoplasm of most cells Long dsRNA (over 2 kb) Picornaviruses (EMCV, polio),
SeV, NDV, VSV, reovirus,
MHV, murine norovirus, dengue
Virus abbreviations: SeV Sendai virus, VSV vesicular stomatitis virus, MCMV murine cytomegalovirus, WNV- west nile virus, NDV- newcastle
disease virus, HCV- hepatitis C virus, JEV Japanese encephalitis virus, EBV Epstein Barr virus, HSV1 Herpes simplex virus 1, EMCV
encephalomyocarditis virus, MHV mouse hepatitis virus
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genes and production of the ﬁrst wave of type I interferon
(Thompson and Locarnini 2007). Following synthesis, IFN
is secreted from the infected cell and initiates an autocrine
and paracrine-signaling cascade through Type I IFN
receptor (IFNAR) which results in upregulation of more
than 100 different genes and creation of an antiviral state in
both infected and neighboring uninfected cells. Although
the functions of the majority of IFN stimulated genes are not
known, some are well characterized and are involved in
inhibition of the viral lifecycle by shutting down general
cellular processes (Samuel 2001). In addition to its antiviral
function, IFN has also been shown to play an important role
in modulation of the adaptive immune response through
stimulation of MHC class I presentation, activation of nat-
ural killer (NK) cells and cytotoxic T cells, and maturation
of dendritic cells (DCs) (Biron 2001; Le Bon and Tough
2002; Stetson and Medzhitov 2006).
TLRs
Toll-like receptors were initially identiﬁed through their
homology to Drosophila Toll protein, a critical component
of Drosophila’s innate immune system (Rock et al. 1998).
To date 13 mammalian members of this family have been
recognized as receptors involved in recognition of
conserved microbial PAMPS (Akira and Hemmi 2003;
Janeway 1989). These receptors are composed of an
extracellular leucine-rich repeat domain which participates
in pathogen recognition, and a conserved cytoplasmic
domain with homology to IL-1R which is involved in
downstream signaling through MyD88 or TRIF adaptor
proteins (Akira and Takeda 2004). The extracellular
domains of TLRs exhibit high structural diversity and have
been shown to recognize a wide variety of pathogens
including bacteria, fungi, protozoa, and viruses. Whereas
TLRs responsible for bacterial and fungal recognition are
located on the cell surface, those responsible for sensing
viral infections are commonly located intracellularly in
endosomal compartments (Diebold 2008). Upon activation,
TLR3 and TLR7/8 initiate a signaling cascade though
adaptors TRIF and MyD88, respectively, leading to
expression of IFN and proinﬂamatory cytokines (Uematsu
and Akira 2007).
TLR3
TLR3 was the ﬁrst characterized receptor to induce IFN
production in response to dsRNA. Mice lacking TLR3
were shown to be more resistant to poly(I:C) induced shock
and TLR3 deﬁcient macrophages exhibited reduced IFN
TLR7
TLR3 RIG-I
MDA5
MyD88 TRIF
MAVS
TRAF6
IRAK1 IRAK4 TBK1 IKKε
IKKγ
IKKα IKKβ
IRF7 IRF3 NF-κB
Type I IFN
ppp
TLR8
Fig. 1 Endosomal and cytoplasmic pathways for virus recognition
and IFN production. In DCs, TLR7 and TLR8 located in endosomal
compartments recognize viral ssRNA through either direct infection,
autophagocytic uptake of viral material from cytoplasm or phagocytic
uptake of other infected cells or vial particles. Both TLR 7 and 8
signal through adaptor MyD88, which through interaction with
IRAK4/IRAK1/TRAF6 complex leads to phosphorylation and acti-
vation of IRF7 and subsequent IFN transcription. TLR3 located in
endosomes of cDCs, macrophages, epithelial cells, and ﬁbroblasts is
activated by encountering dsRNA. Following its activation, TLR3
signals through its adaptor, TRIF which leads to activation of
noncanonical IKK kinases (TBK1/IKKe) and subsequent
phosphorylation and nuclear translocation of IRF3. NF-jB is also
activated by TRIF mediated signaling through canonical IKK kinases
(IKKa, b, and c). Cytoplasmically located RIG-I and MDA5 are
expressed in most cells and recognize 50ppp containing dsRNA or
long dsRNA, respectively. Both of these cytoplasmic sensors upon
activation interact and signal through the mitochondrially located
adaptor MAVS. This signaling pathway, analogous to that of TLR3,
leads to activation of the canonical and noncanonical IKK kinases and
the following nuclear transclocation of NF-jB and IRF3. Concurrent
activation of IRF3 and NF-jB in turn allows for transcription of IFN
genes and its synthesis and export
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123production in response to poly(I:C) (Alexopoulou et al.
2001). It was therefore proposed that this receptor was
primarily responsible for detection of dsRNA generated
during viral infections and induction of IFN. However, the
physiological importance of TLR3 in IFN induction is
questionable in light of a number of studies showing that
loss of this receptor does not result in increased viral sus-
ceptibility or reduced IFN production in the infected ani-
mals. TLR3 knockout mice were shown to recover
normally from multiple RNA viruses, including lympho-
cytic choriomeningitis virus (LCMV), vesicular stomatitis
virus (VSV), and reovirus (ReV) (Edelmann et al. 2004;
Johansson et al. 2007; Kato et al. 2005). Infections of
TLR3 knockout mice with mouse cytomegalovirus
(MCMV), a dsDNA virus, has also led to contradictory
outcomes with one group reporting normal recovery and
IFN production and another reporting increased suscepti-
bility and abrogated IFN levels (Edelmann et al. 2004;
Tabeta et al. 2004). TLR3’s role in cytokine production can
be observed in TLR3 deﬁcient human lung epithelial cells
infected with inﬂuenza virus. In response to infection, these
cells exhibit a reduced induction of NF-kB dependent
genes but not of IRF3 dependent genes, including IFNb (Le
Gofﬁc et al. 2007). In addition to cytokine production,
TLR3 signaling has also been implicated in cross-priming
of CD8 T cells by DC mediated phagocytosis of infected
cells (Schulz et al. 2005), and in activation of NK cells in
response to MCMV infection (Tabeta et al. 2004). Con-
sistent with its role in inducing an inﬂammatory response,
one study showed that mice lacking in TLR3 were more
resistant to West Nile virus (WNV) associated encephalitis,
presumably because of a break down in blood–brain barrier
caused by TLR3 mediated inﬂammation (Wang et al.
2004). However, another more recent study found the
opposite effect, with TLR3 knockout mice being more
susceptible to WNV infection and having higher viral load
in the brain, although IFN levels in these mice were not
diminished (Dafﬁs et al. 2008). Inﬂuenza A infections in
TLR3 deﬁcient mice also resulted in a less pathogenic
phenotype despite a higher virus load in the lungs of the
animals (Le Gofﬁc et al. 2006). Therefore, while it appears
that IFN production in animals does not require TLR3
signaling, most likely because of a functional RLR system,
it is clear that this receptor does play a role in the innate
and adaptive immune responses. As such, people lacking in
TLR3 have been shown to be more susceptible to HSV-1
associated encephalitis (Zhang et al. 2007).
TLR 7 and 8
Unlike TLR3, which is expressed in numerous cell types,
TLR7 and 8 are mainly found in endosomal compartments
of plasmacytoid dendritic cells (pDCs) and myeloid
dendritic cells (mDCs), respectively (Diebold 2008). The
two receptors are very closely related and are thought to
differ primarily in cell-type speciﬁcity and cytokine
expression proﬁles (Gorden et al. 2005). Both TLR 7 and 8
have been determined to be activated by ssRNA rich in
guanosine or uridine, and ssRNA from viruses, such as
human immunodeﬁciency virus (HIV), VSV, and inﬂuenza
A virus (Diebold et al. 2004; Heil et al. 2004; Lund et al.
2004). Interestingly, TLR7 was also shown to be activated
by cellular mRNA but not by rRNA or tRNA, highlighting
the possible importance of cellular RNA modiﬁcations in
preventing stimulation of antiviral RNA receptors (Kariko
et al. 2005). Based on their endoplasmic location and
inaccessibility to cytoplasmically replicating viruses, TLRs
can only be activated by viruses through endocytosis, or by
phagocytic/autophagocytic uptake of viral RNA from the
cytoplasm of infected cells. Therefore, viruses which enter
cells through the endosomes, such as inﬂuenza virus, might
be more easily detected by TLRs than viruses that do not
use the endosome for entry (Diebold et al. 2004). On the
other hand, autophagy has been shown to be necessary in
pDC virus detection of VSV and Sendai virus, which enter
cells through direct fusion with the plasma membrane.
Accordingly, mice deﬁcient in autophagy related gene 5
(Atg5) or pDCs treated with autophagy inhibitors produced
much lower amount of IFN than wild type mice and only
responded to replication competent viruses (Lee et al.
2007). An important role for TLR7 signaling came from
studies that showed that both TLR7 (and its adaptor
MyD88) are essential for IFN production by pDCs fol-
lowing inﬂuenza A virus and VSV infections (Kato et al.
2005). The unique dependence of pDCs on TLR7 signaling
is intriguing in light of these cells’ characterized ability to
produce copious amounts of type I IFN in vitro and their
role in IFN production in vivo (Asselin-Paturel et al. 2001).
Contrary to pDCs, other cell types have been shown to
primarily rely on RLR sensors for RNA virus detection
(Kato et al. 2005). A study by Kumagai et al. provides a
nice illustration of a possible physiological reason for two
parallel IFN inducing systems. In this study, mice were
intranasally infected with either wild type or C protein
deﬁcient Sendai virus (SeV). The authors went onto show
that pDCs, in a MyD88-dependent manner, were the pri-
mary IFN producing cells in response to wild type SeV.
However, when SeV lacking in C protein were used, the
primary IFN producers were alveolar macrophages. These
cells did not rely on MyD88-directed signaling for IFN
production, but instead depended on MAVS (an adaptor for
RIG-I/MDA5 pathway) (Kumagai et al. 2007). Since SeV
C protein is known to inhibit RIG-I mediated IFN induc-
tion it appears that TLR-dependent pDCs are employed as
primary IFN producing cells in the event that MAVS sig-
naling is abrogated by the virus (Strahle et al. 2007). Thus,
Induction of type I interferon by RNA viruses 1287
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for those pathogens, which have evolved mechanisms that
subvert cytoplasmic viral sensors.
TLR7 signaling has also been implicated in having a
role in mediating the antibody response to RNA viruses,
as MyD88 knockout mice are deﬁcient in B cell IgG
class-switching following inﬂuenza infection and are
deﬁcient in CD4 T cell and B cell response following
inﬂuenza vaccination (Heer et al. 2007; Koyama et al.
2007). Thus, it is likely that in addition to their role in
innate immunity, TLRs serve an important function in
triggering signaling pathways leading to establishment of
humoral immunity.
RLRs
Discovered in 2004, the RLR family of cytoplasmic viral
sensors has become a major focus of research in antiviral
innate immunity. The family is composed of three mem-
bers, RIG-I, MDA5, and Laboratory of Genetic and
Physiology 2 (LGP2). Both RIG-I and MDA5 belong to the
family of DExD/H RNA helicases and contain a typical
ATP-dependent helicase domain. The N-terminus of these
proteins is unique in that it encodes two caspase recruit-
ment domains (CARDs), normally associated with cell
death and inﬂammatory signaling pathways. Through
numerous studies RIG-I and MDA5 have been found to
play a key role in IFN induction following RNA virus
infection. Through knockout analysis RIG-I has been
shown to be the primary recognition receptor for majority
of RNA viruses, while MDA5 is the major receptor for
recognition of picornaviruses. Despite their speciﬁcities for
various viral families, the two sensors often have over-
lapping roles and individually contribute to IFN production
in response to infection. Both sensors appear to be acti-
vated by binding to dsRNA, with MDA5 being speciﬁc for
long dsRNA molecules and RIG-I preferring dsRNA with
an exposed 50ppp group. Ubiquitous expression of RIG-I
and MDA5 indicates that these sensors play a role in
antiviral innate immunity in majority of tissues and cell
types.
The third member of the RLR family, LGP2, also con-
tains a DExD/H helicase domain but is completely lacking
in CARDs and is not able to initiate antiviral signaling.
Instead, this protein is thought to act as a regulator of RLR
signaling; a negative one for RIG-I induced signaling and a
positive one for MDA5 induced signaling.
RLR substrates
In line with RIG-I’s prominent role in innate antiviral
immunity, the quest for its physiological substrates has
been a major focus of research in recent years. Based on
the fact that RIG-I is an RNA helicase and was shown
early onto directly interact with poly(I:C), the substrate
responsible for its induction was initially assumed to be
viral dsRNA. However, following up on earlier observa-
tions that siRNAs produced by in vitro transcription were
capable of inducing an antiviral response, two independent
groups showed that in vitro transcribed (IVT) RNA mol-
ecules, of at least 19nt, bearing a 50ppp end can efﬁciently
induce RIG-I (Hornung et al. 2006; Pichlmair et al. 2006).
The importance of the 50ppp was demonstrated by the loss
of IFN induction following Calf Intestinal Alkaline Phos-
photase (CIP) treatment of the RNA and by the fact that a
synthetic ssRNA (with a 50 OH group) of same sequence
was not capable of inducing IFN. Furthermore, RNA iso-
lated from inﬂuenza A or rabies viruses also lost IFN
stimulation activity following CIP treatment and was
unable to induce an IFN response in RIG-I -/- MEFs,
thereby conﬁrming that the presence of phosphates on an
RNA molecule is a physiologically relevant, RIG-I speciﬁc
PAMP (Kato et al. 2006). Small RNA generated by mea-
sles virus polymerase in vitro (likely containing short
leader RNA) also induced IFN-b when transfected into
cells (Plumet et al. 2007). Thus, it appeared that the
presence of a 50ppp on an RNA molecule, either single- or
double-stranded was sufﬁcient for activation of RIG-I. The
concept of a 50ppp PAMP is appealing in that most RNA
viruses contain 50ppp in their genomes and antigenomes,
making this motif an inherent part of a viral lifecycle and
unlikely to be mutated under immune system pressure. On
the other hand, cellular RNAs lack exposed 50ppp as a
result of mRNA capping or processing of 50ppp into
monophosphates (Nallagatla et al. 2008). In addition to
removal of phosphate groups, cellular RNAs are also
extensively modiﬁed as a result of incorporation of
modiﬁed nucleotides or methylation. These modiﬁcations
likely play a role in prevention of an antiviral response to
cellular RNA. In fact, incorporation of pseudourudine,
2-thiouridine, or 20O-methylated uridine into T7 transcripts
strongly inhibited IFN production by those RNA molecules
(Hornung et al. 2006). As a way to prevent exposure of
the 50ppp to the cell, viruses are thought to hide these
molecules in tightly packed nucleocapsids or replicate in
cellular compartments physically removed from the sensors
(Nallagatla et al. 2008). Members of the bunyaviridae
family were shown to remove the triphosphate group from
their genomes, thereby creating genomes that no longer
interact with RIG-I in vitro (Habjan et al. 2008). Since the
discovery of the 50ppp as a PAMP in 2006, it has become
clearly established as a RIG-I speciﬁc recognition motif.
However, challenging the earlier notion that the 50ppp
moiety was sufﬁcient for RIG-I induction are two recent
reports that illustrate a requirement of a double-stranded
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made use of previously unavailable, synthetic 50ppp
ssRNA and observed that this molecule was not capable of
inducing IFN when introduced into cells. However, the
same RNA molecule when generated by T7 in vitro tran-
scription served as a competent activator of the IFN
response. The discrepancy appears to result from aberrant
transcription events generated by the T7 polymerase.
When T7 products were analyzed by gel electrophoresis
and sequencing, it was observed that the RNA mixture
contained a signiﬁcant number of RNA molecules of
double-stranded nature. After polyacrylamide gel separa-
tion, the products corresponding to the true ssRNA size
were no longer capable of inducing an IFN response upon
transfection into cells. Further characterization of RIG-I
activation requirements showed that dsRNA complemen-
tarity of at least 10–18 nt was required at the 50ppp
containing end in order to induce RIG-I activity. The
nature of these types of RNA molecules ﬁts nicely with
the structure of RNA virus panhandles and the ends of
copy back defective interfering (DIs) genomes from
negative strand RNA viruses, which are characterized as
very potent IFN inducers (Strahle et al. 2006). However,
since very short synthetic (19–24 nt) RNA molecules
were analyzed in these studies, it remains to be seen
whether dsRNA structures complementary to the 50ppp
end of an RNA molecule will be required for RIG-I
activation with its natural substrates. Since longer prod-
ucts of T7 transcription also induce IFN, it should also be
determined whether these RNAs are produced with sim-
ilar 50 dsRNA characteristics. Based on numerous studies,
it is very likely that all dsRNA molecules regardless of
length, sequence, phosphates, or overhangs are capable
of binding RIG-I. The question of why some of those
molecules induce RIG-I mediated IFN induction while
others do not has been recently addressed. In a study by
Takahasi et al. (2008), RIG-I was found to be able to bind
any dsRNA molecule regardless of presence of 30 or 50
overhangs, contrary to some earlier ﬁndings by Marques
et al. (2006), and ssRNA molecules containing a 50-ppp,
but not ssRNA containing a 50-OH group or a 50-mono-
phosphate. This group also found that dsRNA molecules
which possessed even a single monophosphate on one
RNA strand were still able to activate RIG-I and induce
IFN. Taking into account reports by Schlee et al. and
Schmidt et al. on the nature of T7 transcribed RNA
products it becomes more challenging to interpret this
data since it is unclear whether true ssRNA species were
analyzed. In addition, the induction of IFN by short
dsRNA with a monophosphate is in disagreement with
reports of Schlee et al. and Schmidt et al. which showed
that a 50 monophosphate group on a dsRNA molecule was
not sufﬁcient for IFN induction. Therefore, it appears that
slight differences between the RNA molecules or cells
used in the three studies might account for the discrep-
ancy of whether a 50ppp is required in the context of a
short dsRNA, or if a single phosphate is sufﬁcient for
RIG-I activation. Nevertheless, it is clear that at least one
phosphate group is required for induction of RIG-I sig-
naling, when short dsRNA is used as substrate. The study
by Takahasi et al. also provides some insightful infor-
mation on the discrepancy between poly(I:C) binding and
signaling. Poly(I:C) has been shown to bind RIG-I with
very high afﬁnity but has been characterized by many
groups to signal through MDA5. To address this apparent
discrepancy, partial protease digestion of RIG-I/poly(I:C)
complex was performed and revealed that this interaction
is different from that of RIG-I with 50ppp-RNA, as dif-
ferent cleavage products were generated (Takahasi et al.
2008). It has not been established whether any viral
RNAs can recapitulate the poly(I:C) phenotype of being
able to bind RIG-I but not activate its signaling.
Another study which provided some clarity concerning
poly(I:C) and dsRNA showed that it was possible to con-
vert poly(I:C) from an MDA5 substrate into a RIG-I sub-
strate by subjecting it to RNAse III digestion, thereby
producing shorter poly(I:C) molecules. The length of the
resultant poly(I:C) molecules directly correlated with their
dependence on either RIG-I or MDA5, with shorter frag-
ments becoming more dependent on RIG-I. The poly(I:C)
cleavage products contain 50 monophosphate ends, sup-
porting the possibility that in the context of some dsRNA
molecules a single phosphate might be sufﬁcient for acti-
vation of RIG-I. Generation of capped dsRNA products of
increasing lengths conﬁrmed the relationship between
length dependent activation of RIG-I and MDA5. Whereas
dsRNA of 1 kb was entirely dependent on RIG-I for IFN
induction, increasing the length to 4 kb progressively led to
dual MDA5 and RIG-I dependence. The authors also
examined the speciﬁcity of RIG-I and MDA5 for the dif-
ferent genomic segments of ReV, a dsRNA virus, previ-
ously characterized to be sensed by both sensors. They
found that the smallest segment was primarily recognized
by RIG-I and the larger ones relied more extensively on
both RIG-I and MDA5 (Kato et al. 2008). In addition, the
authors demonstrated that RNA isolated from VSV infec-
ted cells did not completely lose its ability to induce IFN
following CIP treatment, unlike RNA from inﬂuenza A
infected cells. However, combined digestion of this RNA
with CIP and dsRNA-speciﬁc RNAse III, led to complete
loss of IFN induction. By utilization of a dsRNA speciﬁc
antibody the authors were able to determine that the size of
this molecule in VSV infected cells corresponded to
approximately 2.2 kb, whereas dsRNA from the EMCV
infected cells, a virus dependent on MDA5 for recognition,
was much longer. The effect of poly(I:C) length on RIG-I
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which showed that increasing the length of poly(I:C) cor-
related with MDA5 speciﬁc detection (Ranjith-Kumar et al.
2009). Supporting the claim that RIG-I recognizes shorter
dsRNA is yet another study which found that RIG-I was
responsible for detection of dsRNA produced by coinfec-
tion of cells with Sendai viruses expressing GFP and
antisense GFP (Hausmann et al. 2008). It is important to
keep in mind that in the above studies short dsRNA refers
to RNA species of a few kilobases and the size at which
this RNA is no longer capable of being a RIG-I substrate
has not been determined.
In addition to 50ppp and dsRNA, a possible novel
PAMP was proposed by Saito et al. in a report demon-
strating that RNAs with a high U/A composition induced
IFN more efﬁciently than those without (Saito et al.
2008). In this work, the genomic and replicative inter-
mediate RNAs of HCV were analyzed for their relative
IFN inducing ability. The authors found that the 30NTR
region of the HCV genome was a much more potent
inducer of IFN than other regions of the genome. This
region of HCV genome is particularly rich in polyuradine
tracks and upon further examination this polyU sequence
composition in conjunction with a 50ppp proved to lead to
increased RIG-I activation. Addition of a triphosphate to a
different region of the genome did not improve induction,
showing that sequence components other than the tri-
phosphate group determine the extent of RIG-I activation
(Saito et al. 2008). The conclusions of this work are,
however, confounded by another recent study in which
the authors demonstrated that the uridine-rich 30UTR of
fulminant HCV from strain JFH-1 was a relatively weak
inducer of IFN, contrary to the HCV strain used in the
previous paper (Uzri and Gehrke 2009). Although it
appears that stretches of U or A residues do stimulate the
activity of RIG-I, additional, yet unknown sequence
characteristics determine the RNA’s immunostimulatory
potential. The authors did show that the poly-U region
could be separated from the 50ppp by as much as 300 nt
and still retain signaling activity, thus possibly explaining
how a U-rich 30 RNA sequence can contribute to RIG-I
activation and again implicating the helicase domain in
PAMP recognition.
An interesting possibility for RIG-I activation could
involve production of cellular RNAs capable of acting as
substrates following the initial detection of viral infection.
This type of mechanism would act to stimulate IFN pro-
duction under conditions where viral substrates were lim-
iting, as would presumably be the case early in infection.
Indeed, one example of such a mechanism appears to be
the production of stimulatory RNAs by RNAse L digestion
of cellular mRNA. The resultant small RNAs, with possible
double-stranded composition and 30 monophosphates,
induced an IFN-b reporter in a RIG-I and MDA5 depen-
dent manner (Malathi et al. 2007). Another example of
cell-mediated synthesis of a RIG-I substrates comes from
two recent studies examining the previously reported
(Cheng et al. 2007; Rasmussen et al. 2007, 2009; Samanta
et al. 2006) involvement of the RIG-I pathway in response
to DNA viruses and intracellular bacteria (Ablasser et al.
2009; Chiu et al. 2009). Both reports demonstrate that
poly(dA:dT) when introduced into cells served as a tem-
plate for DNA Polymerase III synthesis of 50ppp containing
dsRNA molecules which in turn activated RIG-I signaling.
Inhibition of Pol III activity in infected cells led to loss of
IFN induction following infection with DNA viruses, such
as Epstein–Barr virus, herpes simplex virus 1 and adeno-
virus, and intracellular bacterium Legionella pneumophila.
Thus, in addition to being the primary receptor for RNA
viruses, RIG-I might potentially play an important role
in recognition of some DNA viruses and intracellular
bacteria.
Identiﬁcation of MDA5 speciﬁc substrates and its mode
of RNA recognition have proven very challenging and its
speciﬁcity for long dsRNA is not understood. Currently, it
appears that while RIG-I can recognize a wide size range of
dsRNA molecules, MDA5 is not able to be activated by
RNA shorter than approximately 2 kb (Kato et al. 2008).
The distinction by RIG-I and MDA5 of such large RNA
molecules is difﬁcult to explain since the proteins are likely
to interact with only a few dozen bases at a time. It is
possible that time spent in translocation mode and the
concurrent ATP hydrolysis could be critical for MDA5
speciﬁc signaling.
RIG-I
Initially identiﬁed by Yoneyama et al. (2004) through a
cDNA library screen for its ability to induce an IRF
reporter upon poly(I:C) treatment, RIG-I has proven to be a
key sensor of RNA virus infections and activator of the
signaling cascade leading to production of type I IFN.
Through a number of studies, RIG-I has been demonstrated
to be the main recognition receptor for multiple RNA
viruses including Newcastle disease virus (NDV), vesicular
stomatitis virus (VSV), Sendai Virus, HCV, Japanese
encephalitis virus (JEV), inﬂuenza A virus, rabies virus,
measles virus, and respiratory syncytial virus (RSV) (Foy
et al. 2005; Hornung et al. 2006; Kato et al. 2005, 2006;
Liu et al. 2007; Melchjorsen et al. 2005; Pichlmair et al.
2006; Rothenfusser et al. 2005). The physiological
importance of RIG-I is highlighted by ex vivo studies from
RIG-I knockout MEFs which show drastically reduced
interferon levels in response to NDV, VSV, SeV, and
inﬂuenza DNS1 virus infections (Kato et al. 2005, 2006).
Infection of RIG-I -/- mice conﬁrm these ﬁndings, as
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upon infection with JEV and VSV (Kato et al. 2006).
The signaling cascade of RIG-I continues to be resolved
and has proven to be distinct than that of the TLR system.
Similar to TLR induction, RIG-I mediated signaling cas-
cade leads to activation of IRF3 and NF-kB (Yoneyama
et al. 2004). However, it was shown early on that knockout
MEFs of key TLR adaptors MyD88 and TRIF, do not have
a defect in RIG-I mediated induction of IFN (Kato et al.
2005;Y o n e y a m ae ta l .2004). The critical adaptor for RIG-I
signaling was simultaneously identiﬁed by four groups as a
mitochondrially located, CARD containing protein MAVS
(also known as IPS-1, VISA, or Cardif). This adaptor is
activated via CARD-CARD association with RIG-I and
initiates a signaling cascade leading to activation of IFN-b
transcription factors and subsequent production of IFN
(Kawai et al. 2005; Meylan et al. 2005; Seth et al. 2005;
Xu et al. 2005).
RIG-I can be divided into three basic domains, the
N-terminal CARD, central helicase domain, and C-terminal
regulatory domain (Fig. 2). The function of these individ-
ual domains has been carefully dissected by biochemical
and structural studies. The N-terminal tandem CARD
domains are required for interaction with the MAVS
CARD domain and downstream signaling. Even though
only the terminal CARD forms the physical interaction
with MAVS, both CARDs are required for signaling and
constructs lacking either domain are dominant negative
(Saito et al. 2007). When expressed alone, the RIG-I
CARD domain induces IFN production in a constitutive,
substrate-independent manner. Interestingly, this phenom-
enon is only observed in the presence of wt RIG-I. When
RIGI -/- cells are transfected with the CARD construct
no signaling is initiated (Saito et al. 2007). Lack of IFN
induction upon overexpression of the full length RIG-I
indicates that RIG-I’s native conformation is in an inactive
state and requires appropriate viral stimulus to undergo a
conformational change required for signaling initiation
(Yoneyama et al. 2004, 2005).
The carboxy-terminal regulatory domain (RD), also
referred to as the repressor domain or carboxy-terminal
domain (CTD) of RIG-I has proven to contain multiple
diverse functions critical to RIG-I activity. Through
mutational analysis, this domain was identiﬁed to posses
the repressor activity responsible for self-inhibition, and
constructs lacking the RD are constitutively active. The
repression of signaling likely occurs through intramolecu-
lar association between the RD and both the CARD and
helicase domains (Saito et al. 2007b; Takahasi et al. 2008).
A conformational change induced by RNA binding leads to
CARD Helicase RD
C1 C2 RIG-I
C1 C2 MDA5
LGP2
MAVS association
MAVS association
ATPase activity
Translocase/helicase activity
dsRNA binding
ATPase activity*
Translocase/helicase activity*
dsRNA binding 
ATPase activity*
Translocase/helicase activity*
dsRNA binding 
dimerization
autorepression
5'ppp binding
dsRNA binding
dsRNA binding
dsRNA binding
RIG-I binding
925aa
1025aa
678aa
II I III Ia IV V VI
II I III Ia IV V VI
II I III Ia IV V VI
MDA5 binding
dimerization
Fig. 2 RLR domains and their function. The RLR proteins can be
divided into three basic domains. (1) The N-terminal CARD domain,
composed of two tandem CARDs. (2) The central helicase domain,
belonging to the DExD/H family of RNA helicases. (3) The unique
C-terminal domain containing multiple regulatory functions (RD).
The CARD domain, present in RIG-I and MDA5 but absent in LGP2,
is required for interaction with MAVS and downstream signaling.
CARD1 (C1) is involved in physical interaction with the CARD
domain of MAVS, whereas CARD2 (C2) of RIG-I undergoes
ubiquitination required for RIG-I activation. The helicase domain
contains six conserved DExD/H helicase motifs and is involved in
translocation/unwinding of RNA and ATP hydrolysis required for
RLR function. The helicase domain is also implicated in RNA
binding for all three RLR members. The RD is required for
recognition and binding of RNA substrates. This domain provides
speciﬁcity for either 50ppp containing RNA (RIG-I) or dsRNA
(MDA5, LGP2). RD is also required for homo- (RIG-I, MDA5) and
hetero- (LGP2) dimer formation, necessary for signaling by these
receptors. The RD of RIG-I additionally provides a unique function of
autorepression, and RIG-I constructs lacking the RD domain consti-
tutively induce IFN in the absence of RNA stimuli. *Activity has not
been shown directly and is assumed based on sequence similarity to
the helicase domain of RIG-I
Induction of type I interferon by RNA viruses 1291
123the unfolding of the molecule and exposure of the CARD
allowing for downstream signaling. Surprisingly, the RD
domain and not the helicase domain was also identiﬁed as
the primary RNA recognition domain of RIG-I (Cui et al.
2008; Takahasi et al. 2008). Structural studies of the RD
have revealed a basic groove located on one side of this
domain and an acidic surface on the opposite side. The
basic groove is believed to serve as a site of 50ppp-RNA
recognition since mutation of key residues (K858, K888,
and H830) within this region led to a loss of RNA binding
in vitro and inability of the mutant RIG-I to rescue the
phenotype of RIG-I -/- MEFs (Takahasi et al. 2008). The
acidic surface on the opposite side of the RD presents a
suitable area for interaction with the CARD domain of
RIG-I. In addition to signaling repression and RNA
recognition, the RD domain has also been characterized as
being required for RIG-I dimerization. Like full length
RIG-I, the RD alone forms dimers in vitro in the presence
of 50ppp-RNA; unlike RIG-I-DRD which is unable to
dimerize in the presence of 50ppp-RNA or synthetic
dsRNA. Complex formation is also observed between
wild-type RIG-I and the RD alone or in conjunction with
the helicase domain, providing a mechanism for the dom-
inant negative phenotype of those mutants (Cui et al. 2008;
Saito et al. 2007b; Yoneyama et al. 2004).
The exact role of the helicase domain in RIG-I activity
has been the most challenging to elucidate. The biochemical
roles of this domain can be separated into two related but
separate enzymatic functions, ATPase activity and helicase/
translocase activity. As with other helicases of the DExD/H
family, ATP hydrolysis is required for the helicase function
of RIG-I. In support of the ATPase requirement are muta-
tional studies illustrating that walker-type ATP binding site
mutants possess a dominant-negative phenotype (Bamming
and Horvath 2009; Yoneyama et al. 2004). Additionally, a
direct relationship between ATPase activity and immuno-
stimulatory potential of RNA molecules is illustrated by in
vitro biochemical analysis with puriﬁed RIG-I protein. The
same biochemical studies, however, also highlight the fact
that while ATP hydrolysis is required for RIG-I signaling it
is not sufﬁcient as a large number of RNA molecules are
capable of inducing ATPase activity in vitro while failing to
induce IFN production upon transfection into cells (Schlee
et al. 2009; Schmidt et al. 2009; Takahasi et al. 2008). A
critical role of the RD domain in ATP hydrolysis has also
been demonstrated, as the helicase domain alone possesses
much lower ATPase activity in vitro in the presence of in
vitro transcribed (IVT) RNA or synthetic dsRNA than RD
with helicase domain (Cui et al. 2008). The role of the
helicase/translocase function of RIG-I remains poorly
understood. It is not clear whether RIG-I unwinds dsRNA
duplexes in vivo or simply translocates on the RNA mole-
cule, leaving it intact. Like all characterized helicases,
RIG-I is capable of unwinding dsRNA in vitro (Takahasi
et al. 2008). However, the rate of helicase activity of RIG-I
in vitro inversely correlated with the immunostimulatory
potential of the RNA substrate. As RNA molecules which
induced highest helicase activity possessed a 30 overhang or
were complexed with DNA in a heteroduplex, it is difﬁcult
to ascertain the relationship of these types of molecules to
the viral lifecycle. On the other hand, the lack of unwinding
by IFN inducing dsRNA could indicate that RIG-I does not
unwind dsRNA in vivo but simply moves along it. Trans-
location activity of RIG is reported in a study by Myong
et al. which illustrated that RIG-I movement on dsRNA
does not involve unwinding of the RNA duplex (Myong
et al. 2009). The same study also found that the rate of
translocation and ATPase activity by full length RIG-I is
much higher on 50ppp containing RNA than on dsRNA with
a5 0OH group. The rate of ATP hydrolysis and translocation
was similar between full length RIG-I on 50ppp containing
RNA with RIG-I-DCARD on synthetic dsRNA, implying
that the displacement of CARD by 50ppp binding of the RD
allows for more rapid RIG-I movement and associated
ATPase activity. Examination of whether change in ssRNA
length or dsRNA length had an effect on translocation rate
indicated that RIG-I translocates on the dsRNA portion of
the molecule. It is important to keep in mind that under
infection conditions the RNA molecules recognized by
RIG-I are likely to be complexed with nucleoprotein in
RNP structures. The demonstrated ability of many helicases
to displace protein from RNP complexes during movement
(Jankowsky and Fairman 2007) could provide an interesting
mechanism for RIG-I substrate recognition where upon
binding to any exposed dsRNA the helicase could proceed
to move along the dsRNA and displace nucleoprotein until a
50ppp group was found at which time the CARDs would be
displaced and signaling could initiate.
Apart from translocation and ATP hydrolysis, the heli-
case domain also appears to have an important role in RNA
binding. In vitro RNA binding assays show that the RNA
afﬁnity of puriﬁed RD alone is not as strong as that of the
full-length protein. Interestingly, analysis of helicase
deletion mutants demonstrated impaired binding afﬁnity to
dsRNA but had little effect on in vitro transcribed RNA
binding, suggesting that the RD and helicase domains
likely recognize different PAMPs within the same RNA
molecule (Bamming and Horvath 2009). The contribution
of the helicase domain to RNA recognition and binding is
further clariﬁed by competition experiments which show
that while the RD domain alone has a preference for any
50ppp molecule (either double or single stranded) the full
length protein prefers to bind dsRNA with 50OH groups
than 50ppp ssRNA (Schmidt et al. 2009). However, in vitro
binding analysis of the puriﬁed helicase domain, failed to
show dsRNA interaction. Therefore, it appears that the RD
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exhibit cooperative binding properties, as neither domain
alone possesses the complete RNA afﬁnity of the full
length molecule (Takahasi et al. 2008). Together these
ﬁndings support the notion that the helicase domain may
only recognize dsRNA molecules, while the RD domain
has speciﬁcity to both dsRNA and the 50ppp.
A large number of proteins have been characterized as
regulators of RIG-I activity in recent years. One of the best
characterized to date is an E3 ubiquitin and ISG15 ligase
tripartite motif protein 25 (TRIM25). TRIM25 acts as a
positive regulator of RIG-I by adding a critical K172 K63-
linked ubiquitin group to the RIG-I CARD domain. The
loss of lysine 172 (and subsequent lack of ubiquitination) is
correlated with loss of RIG-I/MAVS interaction and lack of
IFN production. Supporting an important role of TRIM25
as a positive regulator of IFN response is the reduced
ability of TRIM25 -/- MEFs to produce IFN following
Sendai virus infection (Gack et al. 2007). The unique roles
of RIG-I tandem CARD domains was partially deciphered
when it was shown that CARD1 is required for TRIM25
binding while CARD2 serves as a target for TRIM25
mediated ubiquitination. Therefore, the presence of both
CARDs is necessary for interaction with MAVS. Interest-
ingly, a RIG-I splice variant lacking residues 36–80 in its
ﬁrst CARD domain was identiﬁed as being produced fol-
lowing viral infection. As this splice variant is unable to
undergo TRIM25-mediated ubiquitination, it possesses
dominant negative activity and is proposed to play a role in
negative feedback regulation of RIG-I signaling (Gack
et al. 2008). Supporting an important role of TRIM25 in
activation of RIG-I is a recent study describing inhibition
of TRIM25 activity by inﬂuenza A NS1 protein, a well-
characterized viral antagonist of the innate immune system
(Egorov et al. 1998; Garcia-Sastre et al. 1998). In this
study, NS1 was shown to prevent oligomerization of
TRIM25 by direct interaction and therefore prevent the
ability of TRIM25 to ubiquitinate and activate RIG-I.
Chimeric viruses with NS1 mutations that lack the ability
to bind TRIM25 resulted in an attenuated viral phenotype
(Gack et al. 2009). In addition to TRIM25, a number of
other ubiquitinases and deubiquitinases have been pro-
posed to regulate RIG-I activity. Riplet/RNF135/REUL, an
E3 ligase was identiﬁed by two independent groups and
shown to play a positive role in RIG-I signaling. However,
the two reports diverged on whether the C- or N-terminal
region of RIG-I was being ubiquitinated (Gao et al. 2009;
Oshiumi et al. 2009). Another E3 ligase, RNF125 has been
proposed to negatively regulate RIG-I and target it for
proteosomal degradation (Arimoto et al. 2007). CYLD, a
deubiquitinase, has been proposed to remove polyubiquitin
chains from RIG-I and have a negative effect on RIG-I
signaling (Friedman et al. 2008). RIG-I signaling has also
been shown to be negatively regulated by gC1qR, a mul-
tifunctional ubiquitously expressed protein. Following viral
infection gC1qR was shown to translocate to the mito-
chondria and through its interaction with MAVS inhibits
RIG-I/MAVS association (Xu et al. 2009). ER localized,
stimulator of IFN genes (STING) is the ﬁrst ER resident
protein shown to interact with RIG-I and be required for its
full activity; possibly implicating ER associated functions,
such as translation or stress response in RIG-I signaling
(Ishikawa and Barber 2008).
MDA5
MDA5 was identiﬁed as a DExD/H helicase family
member during a screening of genes, which were upreg-
ulated by IFN treatment and at the same time involved in
growth suppression of melanoma cells. Similar to RIG-I,
MDA5 contains two N-terminal CARD domains, a
dsRNA-dependent ATPase motif within a central helicase
domain, and a regulatory C terminal domain (Kang et al.
2002). The initial report which implicated MDA5 as an
antiviral protein showed that the interferon antagonist V
proteins of Simian Virus 5 (SV5) and of other paramyxo-
viruses interact with MDA5 (Andrejeva et al. 2004).
Later, it was demonstrated that V proteins of all para-
myxoviruses directly bind to MDA5 and prevent its
dsRNA binding and self-association, thereby inhibiting
downstream signaling (Childs et al. 2009). Similarly to
RIG-I in the presence of RNA activators, overexpression
of MDA5 in the presence of poly(I:C) induces activation
of an IFN-b reporter construct and knockdown of
endogenous MDA5 by siRNA inhibits IFN induction
following poly(I:C) transfection (Andrejeva et al. 2004).
Like RIG-I, the truncated CARD domain of MDA5 is
capable of inducing an antiviral response independently of
stimuli, and the helicase domain when expressed alone
possesses a dominant negative phenotype (Andrejeva
et al. 2004). However, unlike RIG-I, the RD of MDA5
does not appear to contain autoinhibitory activity, since
expression of full length MDA5 and MDA5-DRD induce
the same amount of IFN-reporter activation (Saito et al.
2007b). The negative regulation of MDA5 in uninfected
cells is proposed to be maintained by dihydroxyacetone
kinase (DAK), a protein which speciﬁcally inhibits
MDA5 but not RIG-I mediated signaling, and most likely
by other yet undiscovered regulators (Diao et al. 2007).
The signaling cascade of MDA5 appears to be identical to
that of RIG-I, leading to the conclusion that the two
sensors act in parallel after being triggered by their
respective viral PAMPS (Yoneyama et al. 2005). Studies
in MDA5 -/- mice show this receptor to be speciﬁc for
in vivo recognition of poly(I:C) and picornaviruses,
including the encephalomyocarditis virus (EMCV) and
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knockout mice respond normally to JEV and VSV
infections, supporting the importance of a RIG-I depen-
dent recognition of those viruses. The inability of picor-
naviruses to be recognized by RIG-I has been attributed
to the lack of 50ppp in the genome of these viruses.
However, a recent study showing that picornavirus pro-
teinase 3C(pro) speciﬁcally degrades RIG-I, suggests that
this sensor may also play a role in picornavirus infections
(Barral et al. 2009). In addition to recognition of picor-
naviruses, MDA5 has been shown to play a major role in
recognition of a coronavirus Mouse Hepatitis Virus
(MHV) in brain macrophages (Roth-Cross et al. 2008)
and a murine norovirus in DCs (McCartney et al. 2008).
Viruses such as Dengue virus type 2 (DEN2), type 3
Dearing (T3D) reovirus, and type 1 Lang (T1L) reovirus
were shown to be recognized by both RIG-I and MDA5,
illustrating the sometimes overlapping functions of these
two receptors (Loo et al. 2007). The relative contribution
of RIG-I and MDA5 to recognition of any particular virus
appears to be highly cell-type speciﬁc. For example,
Sendai virus is clearly shown to rely on RIG-I sensing in
MEFs (Kato et al. 2006) but is recognized primarily by
MDA5 in DCs (Yount et al. 2008). Since Sendai virus is
known to express both MDA5 and RIG-I speciﬁc inhib-
itors, the ability of this virus to be recognized by both
sensors is not surprising (Strahle et al. 2007). It is unclear
whether this cell-type speciﬁc recognition of viruses is a
result of differential expression of the sensors or whether
cell-type speciﬁc differences in viral replication lead to
different modes of recognition. Together, the above data
lead to a model where MDA5 and RIG-I may possess
both overlapping and distinct roles in RNA virus detec-
tion. For the vast majority of viruses and cell types,
deletion of one of the sensors does not completely abro-
gate IFN induction (Diao et al. 2007; Kato et al. 2006), as
opposed to deletion of the common adaptor MAVS,
which leads to a much more severe phenotype (Kawai
et al. 2005; Meylan et al. 2005; Seth et al. 2005; Xu et al.
2005). It is plausible that many viruses produce RNA
molecules detected by both sensors and the relative
abundance of these molecules dictates which receptor will
play a predominant role in IFN production. An interesting
question is whether most viral infections result in pro-
duction of multiple distinct PAMPs (i.e. misformed RNPs
and double stranded replicative intermediates) or whether
the same basic PAMP is being recognized by both RIG-I
and MDA5 depending on the abundance of these recep-
tors and the substrates.
Structural studies of RD domains of RIG-I, MDA5, and
LGP2 have revealed very similar overall architecture (Cui
et al. 2008; Li et al. 2009a; Murali et al. 2008; Pippig et al.
2009; Takahasi et al. 2008, 2009). All RDs contain four
conserved cysteine residues which participate in zinc
binding and appear necessary for RD function. A basic
surface on one side of the RD is proposed to play a role in
RNA biding for all three receptors, with minor structural
differences accounting for the difference in speciﬁcities
between the molecules (Cui et al. 2008; Pippig et al. 2009;
Takahasi et al. 2008). Binding studies show that unlike
RDs of RIG-I and LGP2, the RD of MDA5 associates very
weakly or not at all with dsRNA or IVT RNA (Cui et al.
2008; Li et al. 2009a; Takahasi et al. 2008, 2009). These
differences in binding are in agreement with values
obtained for full-length proteins, with LGP2 having highest
afﬁnity for dsRNA and MDA5 the weakest (Takahasi et al.
2009; Yoneyama et al. 2005). The weak afﬁnity of MDA5
to dsRNA and poly(I:C) is puzzling in light of its role in
dsRNA detection, and the precise mechanism of MDA5
activation by dsRNA remains to be understood.
LGP2
The third member of the RLR family, LGP2, has been
implicated as a negative regulator of RIG-I and a positive
regulator of MDA; however, the exact role of this molecule
in viral infection remains controversial. Like RIG-I and
MDA5, LGP2 contains a DExH/D box helicase domain
and a carboxy-terminal RD. However, unlike those recep-
tors, it lacks the CARD domain, and therefore, it is unable
to signal through MAVS. Initial studies of LGP2 function
demonstrated that upon overexpression this molecule had a
negative effect on IFN production following Sendai virus
or NDV infection, or poly(I:C) transfection. LGP2 activity
was conﬁrmed to be speciﬁc to RLR signaling as its
expression had no effect on TLR3 mediated IFN induction.
(Rothenfusser et al. 2005; Yoneyama et al. 2005). The role
of LGP2 as a negative regulator of RIG-I signaling was
conﬁrmed in Lgp2 -/- mice infected with VSV (Venka-
taraman et al. 2007). The exact mechanism by which LGP2
interferes with RIG-I signaling has not been resolved. One
possibility is that LGP2 simply sequesters dsRNA from
RIG-I. This potential mechanism is supported by LGP2’s
high binding afﬁnity for poly(I:C) and synthetic dsRNA in
vitro, and the high expression level of this protein fol-
lowing virus infection (Yoneyama et al. 2005). Inhibition
of RIG-I dimer formation has also been proposed as the
possible mode of LGP2 inhibitory activity. This mecha-
nism is supported by observed complex formation between
LGP2 and RIG-I in infected cells and the structural simi-
larity of LGP2 to RIG-I DCARD (Rothenfusser et al. 2005;
Saito et al. 2007a). Finally, observed association of LGP2
with MAVS in virus infected cells leads to a possible third
mechanism for its activity. Komuro et al. demonstrated that
LGP2 was able to compete with IKKe for MAVS binding,
therefore inhibiting a downstream step in RIG-I mediated
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123activation pathway (Komuro and Horvath 2006). The RD
of LGP2 when expressed alone is sufﬁcient to inhibit RIG-I
mediated signaling, but it is not as efﬁcient as full length
LGP2 (Murali et al. 2008). Similarly to RIG-I RD, LGP2
RD is able to bind RNA and form dimers in vitro. The
structure of LGP2 RD is very similar to that of the RIG-I
RD (Pippig et al. 2009). Surprisingly, binding assays with
puriﬁed protein have revealed that LGP2 possesses no
speciﬁcity to 50ppp-RNA, and instead has very high afﬁnity
for any dsRNA, with the presence of phosphate groups
appearing irrelevant. (Murali et al. 2008; Pippig et al.
2009). The RD of LGP2 has been shown to bind to the
blunt-end of dsRNA and not to the phosphate backbone of
the molecule (Li et al. 2009b). Since RIG-I interacts with
both 50ppp-RNA and dsRNA, this ﬁnding still allows LGP2
to inhibit RIG-I signaling by dsRNA sequesteration or
inhibition of RIG-I duplex formation. A recent study
showed that LGP2 defective in RNA binding inhibited
RIG-I to the same degree as wild-type LGP2; supporting
the hypothesis that dsRNA sequesteration is not the pri-
mary mode of LGP2 mediated inhibition (Li et al. 2009b).
Unlike its negative regulation of RIG-I induced sig-
naling, LGP2 appears to have an enhancing effect on
MDA5 speciﬁc IFN induction. Similarly to its complex
formation with RIG-I, LGP2 has been found to interact
with MDA5 in infected cells (Saito et al. 2007a). The
initial observation that LGP2 might act as a positive reg-
ulator of MDA5 came from an observation that LGP2
knockout mice infected with EMCV exhibited reduced
levels of IFN in sera and increased mortality. In agreement
with the in vivo results, LGP2 knockout MEFs were also
severely limited in IFN production after poly(I:C) trans-
fection (Venkataraman et al. 2007). Since the same ani-
mals were more resistant to infections with RIG-I speciﬁc
viruses, these results suggested a differential role of LGP2
in regulation of RIG-I and MDA5 signaling. Supporting
this hypothesis is a recent study showing that poly(I:C)
activation of MDA5 peaked in the presence of an equal
ratio of LGP2, and that LGP2 constructs deﬁcient in RNA
binding or individual domains alone were not capable of
augmenting MDA5 directed signaling (Pippig et al. 2009).
Also supporting the possible unique link between MDA5
and LGP2 is a study showing that paramyxovirus V pro-
teins interact with both MDA5 and LGP2, but not RIG-I.
This helicase domain mediated interaction leads to
reduction of ATPase activity of both receptors (Parisien
et al. 2009). The possible role of LGP2 as a negative
regulator of RIG-I and a positive regulator of MDA5 is
very puzzling since the two receptors are thought to act in
parallel to induce IFN following virus infection. Possible
abundance and expression kinetic differences of these
three proteins in various cell types may account for this
intriguing observation.
Conclusions
Proteins involved in the recognition of viral infection have
only recently been identiﬁed and the initial characterization
of their roles in this intricate system is just now starting to
be understood. Identiﬁcation of the TLR and RLR family
of sensors within the last several years has provided criti-
cally important and necessary information concerning
cellular recognition of RNA viruses. To date, these two
receptor families are the only known systems sufﬁcient for
IFN induction in response to RNA viruses; although evi-
dence from knockout studies point to the existence of other
undiscovered receptors. Other previously described viral
sensors, such as Protein Kinase R (PKR) and 20-50oligoa-
denylate synthetase (2-5 OAS) (together with RNAse L)
are not sufﬁcient for IFN production but likely play a role
in mediating the IFN response. Indeed, PKR is a known
dsRNA-dependent inducer of NFjB, and RNAse L has
recently been shown to be responsible for generation of
endogenous RNA molecules that may be stimulatory to
IFN production (Kumar et al. 1994; Malathi et al. 2007). In
addition, it has been shown that cells lacking in PKR
produce lower amounts on IFN-a after infection with
EMCV, supporting its modulating role in IFN production
(Der and Lau 1995). PKR’s ability to be activated by 50ppp
RNA presents another interesting addition to PAMP/PRR
interaction story (Nallagatla et al. 2007).
The search for viral recognition motifs has been a focus
of virology research for the past 50 years. With the recent
identiﬁcation of proteins involved in viral recognition, the
characteristics of viral motifs that stimulate an antiviral
response are now rapidly being discovered. In addition to
dsRNA, which has become a paradigm molecule for viral
detection, the recent discovery of 50ppp RNA as a possible
viral PAMP adds an important piece to this puzzle. Yet, it
remains to be shown whether these molecules are indeed
physiological triggers of the innate immune system, and if
so whether their presence is sufﬁcient for initiation of the
antiviral response. It is also important to understand if these
RNA molecules are products of viral errors in replication or
are an inherent part of the viral life cycle. By convention,
virologists have assumed that generation of viral PAMPs is
a byproduct of errors in viral replication, and although this
type of PAMP generation likely contributes to viral recog-
nition, it is also possible that a component of the virus
structure or lifecycle becomes recognized by the cell very
early on in viral infection. Indeed, phosphorylation of Ik-B
can be observed as early as ﬁve minutes after infection of
glial cells with measles virus indicating activation of
upstream components almost immediately after virus entry
(Dhib-Jalbut et al. 1999). It is always possible that differ-
ences in virus preparation, cells, and infection conditions
could account for observations which would not be relevant
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123to naturally occurring viruses and infections but it is also
likely that yet undiscovered sensors or viral PAMPs ensure
that infection is recognized immediately in the invaded cell
leading to a more rapid innate immune response.
Modulation of the innate immune response offers
promising and novel approaches for the treatment of
infectious agents, cancer, allergies, and autoimmune dis-
orders. Incorporation of TLR and RLR agonists as adju-
vants in vaccines is likely to offer signiﬁcant increase in
vaccine potency and efﬁciency. Currently the only
approved TLR agonist is imiquimod (a TLR7 agonist from
3 M Pharmaceuticals) which has been used for treatment of
various skin disorders for over 10 years. However, many
other TLR agonists are being actively investigated in ani-
mal studies and clinical trials (Panter et al. 2009). Lipo-
some-nucleic acid complexes which speciﬁcally target
TLR3, TLR7/8, and TLR9 have also shown to be very
effective in treatment of certain cancers and acute viral and
bacterial infections (Dow 2008). Since TLR and RLR sig-
naling often leads to activation of many different cytokines,
it is possible that the use of an array of multiple agonists and
antagonists could potentially be used to ﬁnely regulate the
immune response. Moreover, comprehensive screening and
evaluation of molecules which act as antagonists of TLRs
and RLRs could lead to new insights for the development of
potent therapeutics for treatment of autoimmune disorders.
Despite the wealth of new and exciting information
concerning TLRs and RLR pathways, many questions
remain to be answered. Speciﬁcally, what is the physio-
logical signiﬁcance of each of these systems and which
viral triggers are responsible for their activation. The
problem of how a cell manages to differentiate between
self and non-self remains one of the fundamental questions
in virology and immunology.
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